American Portfolios Advisors Tyme Technologies, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 22, 2023
BUY
$0.87 - $1.26 $1,566 - $2,268
1,800 New
1,800 $2.2 Million
Q3 2020

Mar 22, 2023
BUY
$0.93 - $1.35 $1,674 - $2,430
1,800 New
1,800 $1.76 Million
Q1 2020

Mar 24, 2023
BUY
$0.9 - $1.95 $1,620 - $3,510
1,800 New
1,800 $1.98 Million
Q4 2019

Mar 24, 2023
BUY
$1.0 - $1.49 $1,800 - $2,682
1,800 New
1,800 $2.52 Million
Q2 2019

Mar 24, 2023
BUY
$0.96 - $1.89 $1,728 - $3,402
1,800 New
1,800 $2.2 Million
Q3 2018

Mar 24, 2023
BUY
$2.18 - $3.44 $3,924 - $6,192
1,800 New
1,800 $5 Million
Q2 2018

Mar 24, 2023
BUY
$2.05 - $4.09 $3,689 - $7,362
1,800 New
1,800 $5.69 Million

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email